← Leaderboards
Christopher M. Walker
Research Inst Nationwide Children'S Hosp
$28,677,697
Attributed
$31,813,623
Total exposure
28
Grants
24
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$41,951,217 · 29
By mechanism
U19$15,443,760 · 5
R01$13,751,634 · 5
R37$6,072,446 · 1
U54$4,148,914 · 3
U01$1,346,443 · 1
R56$610,754 · 1
Top collaborators
- Arash Grakoui5 shared
- Jonathan Robert Honegger4 shared
Most similar at Research Inst Nationwide Children'S Hosp
Same institution · by research overlap
- Amit Kapoor$13,758,670
- Kevin M Flanigan$19,837,604
- Salim Khakoo$1,193,663
- Alex Stephen Hartlage$169,718
- Zarife Sahenk$5,260,424
Others in their field
Top investigators on “Hepatitis C Virus”
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Sharon A Nachman · Johns Hopkins University$91,575,784
- Peter B. Gilbert · Fred Hutchinson Cancer Center$77,122,577
- Robert Turner Schooley · University Of Colorado Denver$45,719,253
- Charles R Rinaldo · University Of Pittsburgh At Pittsburgh$44,694,148
- Charles M. Rice · Rockefeller University$42,549,577
Research focus
Hepatitis C VirusImmunityHepatitis CT-LymphocyteImmuneImmune ResponseVirus ReplicationInfectionVirusResponseT Cell ResponseResolutionCd8b1 GeneCd4 Positive T LymphocytesInsightLiverPan GenusMediatingEpitopesVaccinesCellular ImmunityLiver DiseasesPreventChronic Hepatitis C
Grant awards (92)
Defining successful intrahepatic CD4+ T cell responses against the hepatitis C virus$489,389
R01 · FY2025 · AI · contact PI
Strategies to enhance vaccine-primed T cell immunity against HCV$462,865
U19 · FY2024 · AI · contact PI
Strategies to enhance vaccine-primed T cell immunity against HCV$403,901
U19 · FY2023 · AI · contact PI
Strategies to enhance vaccine-primed T cell immunity against HCV$633,674
U19 · FY2022 · AI · contact PI
Persistent hepatitis C virus replication and immunity in pregnancy$609,225
R01 · FY2022 · AI · contact PI
Persistent hepatitis C virus replication and immunity in pregnancy$624,562
R01 · FY2021 · AI · contact PI
Strategies to enhance vaccine-primed T cell immunity against HCV$353,143
U19 · FY2021 · AI · contact PI
T cell Immunity and the Outcome of Acute HCV Infection$714,861
R01 · FY2020 · AI · contact PI
Persistent hepatitis C virus replication and immunity in pregnancy$630,820
R01 · FY2020 · AI · contact PI
T Cell Immunity and HCV Infection Outcome$270,376
U01 · FY2020 · AI · contact PI
T cell Immunity and the Outcome of Acute HCV Infection$729,481
R01 · FY2019 · AI · contact PI
Persistent hepatitis C virus replication and immunity in pregnancy$629,524
R01 · FY2019 · AI · contact PI
T Cell Immunity and HCV Infection Outcome$250,607
U01 · FY2019 · AI · contact PI
T cell Immunity and the Outcome of Acute HCV Infection$745,107
R01 · FY2018 · AI · contact PI
Persistent hepatitis C virus replication and immunity in pregnancy$641,271
R01 · FY2018 · AI · contact PI
T Cell Immunity and HCV Infection Outcome$273,372
U01 · FY2018 · AI · contact PI
T cell Immunity and the Outcome of Acute HCV Infection$758,458
R01 · FY2017 · AI · contact PI
T Cell Immunity and HCV Infection Outcome$275,514
U01 · FY2017 · AI · contact PI
T cell Immunity and the Outcome of Acute HCV Infection$797,768
R01 · FY2016 · AI · contact PI
Persistent hepatitis C virus replication and T cell immunity in pregnancy$584,545
R01 · FY2016 · AI · contact PI
T Cell Immunity and HCV Infection Outcome$276,574
U01 · FY2016 · AI · contact PI
Persistent hepatitis C virus replication and T cell immunity in pregnancy$584,545
R01 · FY2015 · AI · contact PI
HCV-specific T cell response$662,172
R37 · FY2014 · AI · contact PI
Persistent hepatitis C virus replication and T cell immunity in pregnancy$584,545
R01 · FY2014 · AI · contact PI
Strategies to overcome immunity in gene therapy of DMD$362,674
U54 · FY2014 · HD · contact PI
Immunology Resource Core$194,704
U54 · FY2014 · HD · contact PI
HCV-specific T cell response$687,583
R37 · FY2013 · AI · contact PI
Persistent hepatitis C virus replication and T cell immunity in pregnancy$549,473
R01 · FY2013 · AI · contact PI
Strategies to overcome immunity in gene therapy of DMD$378,738
U54 · FY2013 · HD · contact PI
Immunology Resource Core$185,166
U54 · FY2013 · HD · contact PI
HCV-specific T cell response$705,964
R37 · FY2012 · AI · contact PI
Strategies to overcome immunity in gene therapy of DMD$335,238
U54 · FY2012 · HD · contact PI
Persistent hepatitis C virus replication and T cell immunity in pregnancy$242,356
R01 · FY2012 · AI · contact PI
Immunology Resource Core$196,431
U54 · FY2012 · HD · contact PI
HCV-specific T cell response$665,354
R37 · FY2011 · AI · contact PI
Persistent hepatitis C virus replication and T cell immunity in pregnancy$610,754
R56 · FY2011 · AI · contact PI
Strategies to overcome immunity in gene therapy of DMD$315,163
U54 · FY2011 · HD · contact PI
Immunology Resource Core$193,123
U54 · FY2011 · HD · contact PI
INNATE AND ADAPTIVE IMMUNE RESPONSE TO HAV$75,957
P51 · FY2011 · RR · contact PI
INTERFERON GAMMA AND CONTROL OF HCV REPLICATION$32,112
P51 · FY2011 · RR · contact PI
HCV-specific T cell response$673,574
R37 · FY2010 · AI · contact PI
Strategies to overcome immunity in gene therapy of DMD$531,112
U54 · FY2010 · HD · contact PI
Immunology Core$259,222
U54 · FY2010 · NS · contact PI
Immunology Resource Core$186,276
U54 · FY2010 · HD · contact PI
INTERFERON GAMMA AND CONTROL OF HCV REPLICATION$54,366
P51 · FY2010 · RR · contact PI
HCV REPLICATION AND IMMUNITY$47,970
P51 · FY2010 · RR · contact PI
INNATE AND ADAPTIVE IMMUNE RESPONSE TO HAV$2,132
P51 · FY2010 · RR · contact PI
HCV Replication and Immunity$931,641
U19 · FY2009 · AI · contact PI
HCV-specific T cell response$546,488
R37 · FY2009 · AI · contact PI
HCV-Specific Cellular Immunity in Acute Hepatitis C$435,051
U19 · FY2009 · AI · contact PI
Immunology Core$352,113
U54 · FY2009 · NS · contact PI
HCV REPLICATION AND IMMUNITY$101,615
P51 · FY2009 · RR · contact PI
INTERFERON GAMMA AND CONTROL OF HCV REPLICATION$16,783
P51 · FY2009 · RR · contact PI
HCV Replication and Immunity$918,189
U19 · FY2008 · AI · contact PI
HCV-specific T cell response$541,702
R37 · FY2008 · AI · contact PI
HCV-Specific Cellular Immunity in Acute Hepatitis C$436,583
U19 · FY2008 · AI · contact PI
Immunology Core$341,927
U54 · FY2008 · NS · contact PI
HCV REPLICATION AND IMMUNITY$9,453
P51 · FY2008 · RR · contact PI
INTERFERON GAMMA AND CONTROL OF HCV REPLICATION$2,411
P51 · FY2008 · RR · contact PI
HCV Replication and Immunity$898,548
U19 · FY2007 · AI · contact PI
HCV-specific T cell response$523,271
R37 · FY2007 · AI · contact PI
AAV vectors for prevention and therapy of HCV infection$439,834
R01 · FY2007 · AI · contact PI
HCV-Specific Cellular Immunity in Acute Hepatitis C$409,235
U19 · FY2007 · AI · contact PI
Immunology Core$317,027
U54 · FY2007 · NS · contact PI
HCV REPLICATION AND IMMUNITY$92,682
P51 · FY2007 · RR · contact PI
HCV Replication and Immunity$915,804
U19 · FY2006 · AI · contact PI
HCV-specific T cell response$523,850
R37 · FY2006 · AI · contact PI
AAV vectors for prevention and therapy of HCV infection$442,522
R01 · FY2006 · AI · contact PI
HCV-Specific Cellular Immunity in Acute Hepatitis C$402,340
U19 · FY2006 · AI · contact PI
HCV REPLICATION AND IMMUNITY$30,219
P51 · FY2006 · RR · contact PI
HCV Replication and Immunity$948,736
U19 · FY2005 · AI
HCV-specific T cell response$542,488
R37 · FY2005 · AI
AAV vectors for prevention and therapy of HCV infection$408,128
R01 · FY2005 · AI
HCV-Specific Cellular Immunity in Acute Hepatitis C$399,908
U19 · FY2005 · AI
Administrative Core of HC-CRC$66,860
U19 · FY2005 · AI
HCV REPLICATION AND IMMUNITY$24,362
P51 · FY2005 · RR
HCV replication and immunity$1,078,435
U19 · FY2004 · AI
AAV vectors for prevention and therapy of HCV infection$412,047
R01 · FY2004 · AI
HCV REPLICATION AND IMMUNITY$55,275
P51 · FY2004 · RR
HCV replication and immunity$1,047,020
U19 · FY2003 · AI
HCV SPECIFIC T CELL RESPONSES$521,002
R01 · FY2003 · AI
AAV vectors for prevention and therapy of HCV infection$162,538
R01 · FY2003 · AI
HCV REPLICATION AND IMMUNITY$31,929
P51 · FY2003 · RR
HCV replication and immunity$960,172
U19 · FY2002 · AI
HCV SPECIFIC T CELL RESPONSES$481,745
R01 · FY2002 · AI
HCV cellular immune responses in hepatitis C$434,202
U19 · FY2002 · AI
HCV replication and immunity$1,134,402
U19 · FY2001 · AI
HCV SPECIFIC T CELL RESPONSES$491,096
R01 · FY2001 · AI
HCV cellular immune responses in hepatitis C$434,202
U19 · FY2001 · AI
HCV replication and immunity$1,304,647
U19 · FY2000 · AI
HCV SPECIFIC T CELL RESPONSES$476,792
R01 · FY2000 · AI
HCV cellular immune responses in hepatitis C$434,202
U19 · FY2000 · AI